Arrakis Therapeutics is a startup based in the United States, 4 tracked investors.
Based in the United States, Arrakis Therapeutics is a startup founded in 2016. Brouky records 4 investors associated with the company.
Arrakis Therapeutics develops small molecule drugs that target RNA structures to treat various diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.